Brown Ryan Edward has filed 21 insider transactions across 1 company since March 2024.
Most recent transaction: a option exercise of 6250 shares of Sarepta Therapeutics, Inc. ($SRPT) on June 21, 2024.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | M | Common Stock | 6250 | $0.00 | 34,938.0000 | 92,398,000 | 21.79% | 0.01% |
| June 24, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | F | Common Stock | 2352 | $164.64 | 32,586.0000 | 92,398,000 | 6.73% | 0.00% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | M | Common Stock | 23500 | $62.77 | 56,086.0000 | 92,398,000 | 72.12% | 0.03% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 7644 | $158.07 | 48,442.0000 | 92,398,000 | 13.63% | 0.01% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 2200 | $159.14 | 46,242.0000 | 92,398,000 | 4.54% | 0.00% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 975 | $160.31 | 45,267.0000 | 92,398,000 | 2.11% | 0.00% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 4168 | $161.82 | 41,099.0000 | 92,398,000 | 9.21% | 0.00% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 17581 | $162.65 | 23,518.0000 | 92,398,000 | 42.78% | 0.02% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 3840 | $163.53 | 19,678.0000 | 92,398,000 | 16.33% | 0.00% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 2549 | $164.52 | 17,129.0000 | 92,398,000 | 12.95% | 0.00% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | A | Performance Stock Units | 5500 | $0.00 | 5,500.0000 | 92,398,000 | 9999.99% | 0.01% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | A | Performance Stock Units | 6250 | $0.00 | 6,250.0000 | 92,398,000 | 9999.99% | 0.01% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | M | Performance Stock Units | 6250 | $0.00 | 0.0000 | 92,398,000 | 100.00% | 0.01% |
| June 25, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | M | Stock Option (right to buy) | 23500 | $0.00 | 0.0000 | 92,398,000 | 100.00% | 0.03% |
| March 7, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | F | Common Stock | 506 | $120.49 | 29,587.0000 | 92,398,000 | 1.68% | 0.00% |
| March 8, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | F | Common Stock | 899 | $123.14 | 28,688.0000 | 92,398,000 | 3.04% | 0.00% |
| March 4, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | F | Common Stock | 1734 | $125.32 | 30,093.0000 | 92,398,000 | 5.45% | 0.00% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | F | Common Stock | 269 | $126.19 | 27,827.0000 | 92,398,000 | 0.96% | 0.00% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | A | Common Stock | 6000 | $0.00 | 33,827.0000 | 92,398,000 | 21.56% | 0.01% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | S | Common Stock | 2000 | $125.34 | 31,827.0000 | 92,398,000 | 5.91% | 0.00% |
| March 1, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Brown Ryan Edward | EVP, General Counsel | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 92,398,000 | 50.00% | 0.01% |